{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pink Prescribing: Bismuth Subsalicylate; History, Actions, Risks, and Future Use

Activity Steps

Purpose of Activity

To provide information on the history, actions, risks, and future use of bismuth subsalicylate (BSS).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Summarize the history, pharmacokinetics, and uses of BSS.
  2. Recognize potential adverse effects of and drug interactions with BSS.
Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: CNS0320
Published: Mar/Apr 2020
Expires: 3/4/2022
Passing Score: 11/15 (73%)
Authors: Patricia Anne O'Malley, PhD, APRN-CNS